G1691A
· 8 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| variant | G1691A | “While the Factor V Leiden (FVL) G1691A mutation is a recognized genetic risk factor for thrombophilia in Caucasian and Middle Eastern populations, its role in African pediatric SCD patients remains unclear.” | 0.82 | literature_variant_regex_v2 |
| variant | G1691A | “The aim of this study was to investigate the current prevalence of the G1691A mutation in the FVL gene in the capital city's King Khalid University Hospitals (KKUH).” | 0.82 | literature_variant_regex_v2 |
| variant | G1691A | “Reports on relationship between Factor V G1691A single nucleotide gene polymorphism and ischemic stroke have revealed inconsistent results.” | 0.82 | literature_variant_regex_v2 |
| variant | G1691A | “Analysis of factor V Leiden (G1691A) and factor II (G20210A) mutations was also done.” | 0.82 | literature_variant_regex_v2 |
| variant | G1691A | “Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in Saudi newborns with stroke.” | 0.82 | literature_variant_regex_v2 |
| variant | G1691A | “Factor V Leiden mutation (FVL; G1691A) is an established risk factor for venous thromboembolic disorders.” | 0.82 | literature_variant_regex_v2 |
| variant | G1691A | “Inherited or acquired prothrombotic states play a key role in the development of this disease, such as factor V G1691A mutation (FV Leiden).” | 0.82 | literature_variant_regex_v2 |
| variant | G1691A | “Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.” | 0.82 | literature_variant_regex_v2 |